Intracellular dynamics of HIV infection

Journal of Virology

Volumn 88, Issue 2, 2014, Pages 1113-1124

  Petravic, Janka ^a   Ellenberg, Paula ^b   Chan, Ming Liang ^a   Paukovics, Geza ^b   Smyth, Redmond P ^b,e   Mak, Johnson ^b,c,d   Davenport, Miles P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BURNET INSTITUTE   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d CSIRO   (Australia)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL COUNT; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VIRUS ENTRY;

APOPTOSIS; CELLS, CULTURED; HALF-LIFE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; VIRAL PROTEINS;

EID: 84891681304     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02038-13     Document Type: Article

References (31)

1. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, Markowitz M, Moore JP, Perelson AS, Ho DD. 1999. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354:1782-1785. http://dx.doi.org/10.1016/S0140-6736(99)02035-8.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126. http://dx.doi.org/10.1038/373123a0.
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122. http://dx.doi.org/10.1038/373117a0.
4. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586. http://dx.doi.org/10.1126/science.271.5255.1582.
5. Ciuffi A, Bleiber G, Muñoz M, Martinez R, Loeuillet C, Rehr M, Fischer M, Günthard HF, Oxenius A, Meylan P, Bonhoeffer S, Trono D, Telenti A. 2004. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection. J. Virol. 78:10747-10754. http://dx.doi.org/10.1128/JVI.78.19.10747-10754.2004.
6. Reilly C, Wietgrefe S, Sedgewick G, Haase A. 2007. Determination of simian immunodeficiency virus production by infected activated and resting cells. AIDS 21:163-168. http://dx.doi.org/10.1097/QAD.0b013e328012565b.
7. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus K, Reimann K, Reinhart T, Rogan M, Cavert W, Miller C, Veazey RS, Notermans D, Little S, Danner SA, Richman DD, Havlir D, Wong J, Jordan HL, Schacker TW, Racz P, Tenner-Racz K, Letvin NL, Wolinsky SM, Haase AT. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286:1353. http://dx.doi.org/10.1126/science.286.5443.1353.
8. Li Q, Duan L, Estes JD, Ma Z-M, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148-1152. http://dx.doi.org/10.1038/nature03513.
9. Gilchrist MA, Coombs D, Perelson ASAS. 2004. Optimizing within-host viral fitness: infected cell lifespan and virion production rate. J. Theor. Biol. 229:281-288. http://dx.doi.org/10.1016/j.jtbi.2004.04.015.
10. Ho DD, Huang Y. 2002. The HIV-1 vaccine race. Cell 110:135-138. http://dx.doi.org/10.1016/S0092-8674(02)00832-2.
11. Haase AT, Stowring L, Harris JD, Traynor B, Ventura P, Peluso R, Brahic M. 1982. Visna DNA synthesis and the tempo of infection in vitro. Virology 119:399-410. http://dx.doi.org/10.1016/0042-6822(82)90099-X.
12. Althaus CL, De Vos AS, De Boer RJ. 2009. Reassessing the human immunodeficiency virus type 1 life cycle through age-structured modeling: life span of infected cells, viral generation time, and basic reproductive number, R0. J. Virol. 83:7659-7667. http://dx.doi.org/10.1128/JVI.01799-08.
13. Kutsch O, Benveniste EN, Shaw GM, Levy DN. 2002. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76:8776-8786. http://dx.doi.org/10.1128/JVI.76.17.8776-8786.2002.
14. Jordan A, Defechereux P, Verdin E. 2001. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20:1726-1738. http://dx.doi.org/10.1093/emboj/20.7.1726.
15. Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV. 2005. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 122:169-182. http://dx.doi.org/10.1016/j.cell.2005.06.006.
16. Mohammadi P, Desfarges S, Bartha I, Joos B, Zangger N, Muñoz M, Günthard HF, Beerenwinkel N, Telenti A, Ciuffi A. 2013. 24 hours in the life of HIV-1 in a T cell line. PLoS Pathog. 9:e1003161. http://dx.doi.org/10.1371/journal.ppat.1003161.
17. Goff S, Traktman P, Baltimore D. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
18. Jones KL, Roche M, Gantier MP, Begum NA, Honjo T, Caradonna S, Williams BRG, Mak J. 2010. X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells. J. Biol. Chem. 285:18603-18614. http://dx.doi.org/10.1074/jbc.M109.090126.
19. Yoshizuka N, Yoshizuka-Chadani Y, Krishnan V, Zeichner SL. 2005. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway. J. Virol. 79:11366-11381. http://dx.doi.org/10.1128/JVI.79.17.11366-11381.2005.
20. Duffy KR, Wellard CJ, Markham JF, Zhou JHS, Holmberg R, Hawkins ED, Hasbold J, Dowling MR, Hodgkin PD. 2012. Activation-induced B cell fates are selected by intracellular stochastic competition. Science 335:338-341. http://dx.doi.org/10.1126/science.1213230.
21. Corish P, Tyler-Smith C. 1999. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng. 12:1035-1040. http://dx.doi.org/10.1093/protein/12.12.1035.
22. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222. http://dx.doi.org/10.1016/0092-8674(90)90802-L.
23. Lloyd AL. 2001. The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data. Proc. Biol. Sci. 268:847-854. http://dx.doi.org/10.1098/rspb.2000.1572.
24. Nelson PW, Perelson AS. 2002. Mathematical analysis of delay differential equation models of HIV-1 infection. Math. Biosci. 179:73-94. http://dx.doi.org/10.1016/S0025-5564(02)00099-8.
25. Althaus CL, De Boer RJ. 2010. Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy. Mol. Syst. Biol. 6:1-8. http://dx.doi.org/10.1038/msb.2010.4.
26. Duverger A, Jones J, May J, Bibollet-Ruche F, Wagner FA, Cron RQ, Kutsch O. 2009. Determinants of the establishment of human immunodeficiency virus type 1 latency. J. Virol. 83:3078-3093. http://dx.doi.org/10.1128/JVI.02058-08.
27. Kent SJ, Reece JC, Petravic J, Martyushev A, Kramski M, De Rose R, Cooper DA, Kelleher AD, Emery S, Cameron PU, Lewin SR, Davenport MP. 2013. The search for an HIV cure: tackling latent infection. Lancet Infect. Dis. 13:614-621. http://dx.doi.org/10.1016/S1473-3099(13)70043-4.
28. Cooper A, García M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. 2013. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 498:376-379. http://dx.doi.org/10.1038/nature12274.
29. Klatt NR, Shudo E, Ortiz AM, Engram JC, Paiardini M, Lawson B, Miller MD, Else J, Pandrea I, Estes JD, Apetrei C, Schmitz JE, Ribeiro RM, Perelson AS, Silvestri G. 2010. CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog. 6:e1000747. http://dx.doi.org/10.1371/journal.ppat.1000747.
30. Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, Ignacio CC, Russell T, Pillai SK, Looney DJ, Dandekar S. 2010. In vivo CD8+ T-cell suppression of SIV viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog. 6:e1000748. http://dx.doi.org/10.1371/journal.ppat.1000748.
31. Balamurali M, Petravic J, Loh L, Alcantara S, Kent SJ, Davenport MP. 2010. Does cytolysis by CD8+ T cells drive immune escape in HIV infection? J. Immunol. 185:5093-5101. http://dx.doi.org/10.4049/jimmunol.1002204.